BIOMERIEUX (EPA:BIM) | Finanzwire

Basculer en Français

9821	Companies
197095	Keywords
128171	Articles
104822	Press releases

Home
Companies
BIOMERIEUX

REGULATED PRESS RELEASE

published on 05/28/2024 at 18:01, 1 year 8 months ago

bioMérieux receives FDA 510(k) clearance of VIDAS® TBI (GFAP, UCH-L1), an innovative test to improve the assessment of patients with mild traumatic brain injury
bioMérieux receives FDA 510(k) clearance of VIDAS TBI (GFAP, UCH-L1), a serum-based test to support the assessment of patients with mild traumatic brain injury, improving patient outcomes. The test uses biomarkers to predict absence of acute intracranial lesions

BioMérieux FDA 510(k) Clearance Biomarkers VIDAS TBI Mild Traumatic Brain Injury
BRIEF

published on 05/23/2024 at 13:07, 1 year 8 months ago

Malawi Ministry of Health, bioMérieux, and Pfizer Form Country's First Multisectoral Collaboration to Address Antimicrobial Resistance

BioMérieux Antimicrobial Resistance Public Health Pfizer Malawi Health
REGULATED PRESS RELEASE

published on 05/23/2024 at 13:02, 1 year 8 months ago

Malawi Ministry of Health, bioMérieux, and Pfizer Form Country’s First Multisectoral Collaboration to Help Address Antimicrobial Resistance
Malawi Ministry of Health, bioMérieux, and Pfizer collaborate to address antimicrobial resistance in Malawi through infection prevention, control, diagnostics, and surveillance. The initiative aims to combat AMR, a global health threat

BioMérieux Antimicrobial Resistance Collaboration Pfizer Malawi Ministry Of Health
BRIEF

published on 05/06/2024 at 17:23, 1 year 9 months ago

BioMérieux financial update: Overview of share capital and voting rights in April 2024

Share Capital Voting Rights BioMérieux Actions In Vitro Diagnostics
BRIEF

published on 04/09/2024 at 07:20, 1 year 9 months ago

BioMérieux Outlines Ambitious Five-Year Strategic Growth Plan

Corporate Social Responsibility BioMérieux In Vitro Diagnostics Sustainable Growth GO•28 Strategic Plan
REGULATED PRESS RELEASE

published on 04/09/2024 at 07:15, 1 year 9 months ago

bioMérieux presents its new 5-year strategic plan and its targets for profitable growth
bioMérieux unveils its 5-year strategic plan, GO•28, aimed at sustainable growth and responsiblity. Targets include +7% organic revenue growth and -50% GHG emissions by 2030

BioMérieux Strategic Plan Organic Growth GHG Emissions GO•28
BRIEF

published on 04/09/2024 at 07:06, 1 year 9 months ago

BioMérieux Posts Strong First-Quarter 2024 Results with Outstanding Sales Growth

BioMérieux In Vitro Diagnostics First-Quarter 2024 BIOFIRE® Panels SPOTFIRE®
REGULATED PRESS RELEASE

published on 04/09/2024 at 07:01, 1 year 9 months ago

bioMérieux – First-Quarter 2024 Business Review
bioMérieux reports strong +10% organic sales growth in the first quarter of 2024, driven by BIOFIRE® and microbiology segments. Sales reach €965 million. Company confirms 2024 guidance for sales and operating profit

BioMérieux Organic Sales Growth 2024 Guidance BIOFIRE® Microbiology
BRIEF

published on 04/05/2024 at 09:04, 1 year 10 months ago

BioMérieux announces its number of shares and voting rights for March 2024

Share Capital Voting Rights BioMérieux Actions March 2024
BRIEF

published on 04/05/2024 at 07:06, 1 year 10 months ago

BioMérieux and Mérieux NutriSciences Launch Collaborative Data-Driven Initiative for Food Safety

BioMérieux Food Safety Industry Collaboration Data-driven Initiative Consumer Safety

Accesswire

Published on 02/07/2026 at 01:00, 1 day 16 hours ago

Green Bridge Metals Can Help Secure U.S. Production of Critical Mineral Titanium
Published on 02/06/2026 at 23:10, 1 day 18 hours ago

Topline Capital Management, LLC Announces Disposition of Shares of NamSys Inc.
Published on 02/06/2026 at 22:01, 1 day 19 hours ago

Totec Resources Announces Listing of Shares on the Frankfurt Stock Exchange and Adoption of Omnibus Incentive Plan
Published on 02/06/2026 at 15:30, 2 days 2 hours ago

Vulcan Minerals Inc. - Drilling Program Update for the Carbonear Zinc-Lead SEDEX project in Newfoundland
Published on 02/06/2026 at 13:30, 2 days 4 hours ago

Redwood AI Corp. (formerly Marshall Technologies Corp.) Announces Closing of IPO and Listing of Shares on the Canadian Securities Exchange

View all ACCESSWIRE

EQS Group

Published on 02/07/2026 at 21:00, 20 hours 51 minutes ago

Alibaba Group Debuts 'Wonder on Ice,' an Immersive AI Experience at Milan’s Sforza Castle for Milano Cortina 2026
Published on 02/07/2026 at 16:35, 1 day 1 hour ago

The Ministry of Finance and the International Monetary Fund to launch tomorrow the second edition of the AlUla Conference for Emerging Market Economies
Published on 02/07/2026 at 16:20, 1 day 1 hour ago

NOTICE OF SETTLEMENT APPROVAL HEARING - SHORT FORM - WAYLAND GROUP CORP., SCOTT LANGILLE, GERHARD MÜLLER, PAUL PATHAK, ERIC SILVER, MICHAEL STEIN, JOHN DOES 1-3, CANACCORD GENUITY CORP., AND RF SECURITIES CLEARING LP (FORMERLY KNOWN AS GMP SECU
Published on 02/06/2026 at 19:25, 1 day 22 hours ago

Funding Circle Holdings plc: POS-Transaction in Own Shares
Published on 02/06/2026 at 17:52, 1 day 23 hours ago

EQS-Adhoc: Avemio AG: Preparation of the filing for insolvency proceedings by Teltec AG, a subsidiary of Avemio AG, and potential effects on the going-concern assessment of Avemio AG

Les Echos

Published on 02/06/2026 at 18:22, 1 day 23 hours ago

Disclosure of Share Capital and Voting Rights as of January 31, 2026
Published on 02/06/2026 at 16:01, 2 days 1 hour ago

Notice of exercise of early redemption option of the subordinated note ISIN : FR0010093328
Published on 02/05/2026 at 19:24, 2 days 22 hours ago

Minutes of the Combined General Meeting
Published on 02/05/2026 at 18:24, 2 days 23 hours ago

LNA SANTE : 2025 annual sales
Published on 02/05/2026 at 18:06, 2 days 23 hours ago

Aéroports de Paris SA - Shares and voting rights as of 31 January 2026

View all LES ECHOS COMFI WIRE